logo
Select company
Select metric
$ 151.66MGross Profit
VS
Market
45
Sector
73
Industry
88
History
65
$ 3.16Close
$ 1.37 - $ 4.01 52-Week Range
Ticker Information

Ticker

AKBA

Company Name

AKEBIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AKEBIA THERAPEUTICS INC - Gross Profit Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AKBA - GP Historical data
DateGross Profit
6/30/2025$ 151.66M
3/31/2025$ 125.71M
12/31/2024$ 97M
9/30/2024$ 108.4M
6/30/2024$ 109.17M
3/31/2024$ 121.66M
12/31/2023$ 120.47M
9/30/2023$ 141.16M
6/30/2023$ 128.14M
3/31/2023$ 198.09M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) GP stands at $ 37.34M.
  • Over the past 5 years, AKEBIA THERAPEUTICS INC's average GP has been $ 103.02M.
  • The median GP for AKEBIA THERAPEUTICS INC during this period was $ 114.82M
  • AKEBIA THERAPEUTICS INC reached its highest GP over the past 5 years at $ 207.81M.
  • The lowest GP recorded by AKEBIA THERAPEUTICS INC in the same timeframe $ -43.67M

AKEBIA THERAPEUTICS INC's GP vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

GP Benchmarks
CompanyGP
STOK : STOKE THERAPEUTICS INC $ 199.89MDNA : GINKGO BIOWORKS HOLDINGS INC $ 182.32MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ 176.42MGERN : GERON CORP $ 160.81MIOVA : IOVANCE BIOTHERAPEUTICS INC $ 49.75MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ 62.83MKROS : KEROS THERAPEUTICS INC $ 232.84MCRMD : CORMEDIX INC $ 116.16MNAGE : NIAGEN BIOSCIENCE INC $ 73.99MZYME : ZYMEWORKS INC $ 122.87M

Definition of Gross Profit

[Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].

AKBA - Gross Profit, Last 5 years

$ -43.67M

Minimum

Mar 31, 2021

$ 207.81M

Maximum

Dec 31, 2022

$ 103.02M

Average

$ 114.82M

Median

GP Benchmark Analysis

The chart above depicts the distribution of GP for companies in the Total Stock Market. The average GP of the companies is $ 245.12M with a standard deviation of $ 328.2M.
The following table provides additional summary stats:
GP in the Market:
filtered constituents3.34K
min$ -790.38M
max$ 1.32B
average$ 245.12M
median$ 92.73M
std$ 328.2M